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Abstract. Agglutination and rosette formation are in vitro characteristics of Plasmodium falciparum–infected
erythrocytes, which have been associated with host protective immune responses and also with parasite virulence.
The present study was carried out in an area of seasonal and unstable malaria transmission in eastern Sudan. Plasma
samples were obtained before, during, and after the transmission season from a volunteer cohort of 64 individuals
seven years of age and older. These plasmas were assayed for their ability to agglutinate cultured parasitized eryth-
rocytes originally obtained from acute malaria infection samples taken from five of the cohort members. Our data
show that the capacity of donor plasma samples to agglutinate parasitized cells depended largely on the time of
sampling relative to the transmission season, at least within this epidemiologic setting. Thus, although less than half
of the pretransmission season samples could agglutinate any of the five lines of cultured parasites, all post-transmission
season samples could agglutinate at least one of the parasite lines, with 74% agglutinating two or more lines. This
increase in the agglutination capacity of individual plasma samples after the transmission season occurred essentially
regardless of whether an individual had experienced a clinical malaria attack during the transmission season. The
study thus confirms the acquisition of agglutinating antibodies following episodes of clinical malaria, but also dem-
onstrates that such acquisition can take place in the absence of disease, presumably as a consequence of subclinical
infection. This is the first demonstration of marked seasonal fluctuations in the capacity of individuals’ sera to
agglutinate parasitized red blood cells. Possible explanations for this effect include a decrease in the levels of agglu-
tinating antibodies between seasons, or shifts in the antigens being recognized by such antibodies from one trans-
mission season to the next. Finally, we showed the existence of marked seasonal fluctuation in the levels of agglu-
tinating antibodies, either because levels of such antibodies are not sustained between seasons or because the antigens
recognized change from one season to the next.
Erythrocytes infected by Plasmodium falciparum express
highly variable parasite-derived neoantigens at the red blood
cell surface membrane during the later stages of their devel-
opment.1–3 Predominant among these antigens is PfEMP-1,
an extremely polymorphic molecule encoded by the recently
identified var gene family.4–6 Antibodies responsible for ag-
glutination (cross-linking) of P. falciparum-infected eryth-
rocytes have been shown to specifically recognize variable
antigens on the surface membrane of infected erythro-
cytes,7, 8 and acquisition of protective immunity has been
proposed to reflect the cumulative recognition of such anti-
gens.9 In line with this hypothesis, the ability of sera to ag-
glutinate parasitized erythrocytes has been shown to corre-
late with relative protection of the serum donor from clinical
disease in a study from The Gambia.10
The present study was designed to investigate plasma-in-
duced parasite agglutination in a region of seasonal and un-
stable malaria transmission. We examined the relationship
between the agglutination properties of the plasma samples,
the time the samples were collected relative to the malaria
season, and whether the plasma donors had clinical malaria
episodes during the malaria season.
MATERIALS AND METHODS
Study area. The study was conducted in Daraweesh, a
village of 120 thatched mud huts situated 14 km south of
the town of Gedaref, Sudan, 450 km southeast of the capital
of Khartoum. Bed nets and chemoprophylaxis are not used
in the village. The area is mesoendemic for P. falciparum
malaria, with seasonal and unstable transmission, usually
peaking in October–November, following the annual rainy
season.11, 12 Little, if any, transmission occurs from January
through July. The predominant malaria species is P. falcip-
arum (98%), with P. vivax and P. malariae occasionally
seen.
Donors. A cohort of 64 individuals (age range 5 7–32
years) volunteered to participate in the study. Participating
individuals were requested to present to a health-team pres-
ent in the village on a daily basis when not feeling well.11
No carriers of the sickle-cell hemoglobin (HbS) allele were
included in the study. The study receiced ethical clearance
from The Ethical Committee of the University of Khartoum.
Plasma. Blood samples (15–20 ml) were collected by ve-
nipuncture into heparinized vacutainers (Becton Dickinson,
Rutherford, NJ). A total of 144 blood samples were collected
after informed consent was obtained. Fifty-four of the sam-
ples were collected at the beginning of the malaria season
in September, when all donors were without clinical or mi-
croscopic evidence of malaria infection. An additional sam-
ple was collected from 28 of 31 cohort donors who experi-
enced uncomplicated, microscopically confirmed, P. falcip-
arum malaria during the season. Finally, a total of 62 sam-
ples were collected at the end of the season in December–
January, when all donors were again without evidence of
malaria. Of these latter samples, 29 were obtained from do-
nors who had had at least one clinical malaria episode during
the malaria season, while the remaining were from donors
without such episodes.
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Following centrifugation of the blood samples, plasma
was collected and kept frozen at 2208C until use. In addi-
tion, aliquots of the erythrocyte pellet were stored frozen in
liquid nitrogen or at 2808C for subsequent parasite poly-
merase chain reaction (PCR) analysis.
Parasites. From five donors with clinical P. falciparum
malaria infections, pelleted parasitized erythrocytes were
collected from the blood sample, washed three times in
RPMI 1640 medium (Gibco, Paisley, United Kingdom), re-
suspended in glycerol cryopreservation medium, and trans-
ferred to liquid nitrogen as previously described,13 where
they were stored until brought into in vitro culture. The par-
asite donors were a 10-year-old male (2I4), a 12-year-old
female (X7), a 17-year-old female (2L5), a 20-year-old fe-
male (2A3), and a 32-year-old male (2I1).
Parasite isolates from the above donors were cultured as
previously described.14 For the first multiplication cycle, the
parasites were kept in autologous erythrocytes, while all the
isolates were subsequently maintained in blood-group O1
erythrocytes from a single donor. Medium was changed, and
parasite growth was monitored six times a week.
Microagglutination assay. The ability of plasma samples
to induce antibody-mediated agglutination of parasitized
erythrocytes was measured by modifications of previously
published protocols.15, 16 Parasites multiplied in vitro until
parasitemias of at least 1 % were reached. Erythrocytes were
then washed in phosphate-buffered saline (PBS) and the hae-
matocrit adjusted to 20%. Fifty-microliter aliquots of eryth-
rocyte pellet, 25 ml of PBS containing 40 mg/ml of ethidium
bromide, and 5 ml of test plasma were dispensed into 96-
well microtiter plates (Nunc, Rødovre, Denmark). The plates
were then sealed and incubated on a shaker (10 rpm) at 378C
for 1 hr. Subsequently, 1-ml samples were mounted on mul-
tispot slides under coverslips and examined microscopically
under visual and UV light. The ability to agglutinate and
size of the largest agglutinates were recorded.
Parasite PCR. Parasite DNA was prepared from eryth-
rocyte pellets essentially as described.17 Briefly, 20 ml of
erythrocyte pellet was added to 500 ml of ice-cold 5 mM
sodium phosphate (pH 8), vortexed, and centrifuged for 10
min. This washing procedure was repeated four times. Fi-
nally, pellets were resuspended in 50 ml of sterile water, and
boiled for 10 min before storage at -708C until use as tem-
plate DNA in the PCR.
The PCR analysis was carried out essentially as previous-
ly described.17 Genotyping of the parasite DNA samples was
carried out using the P. falciparum merozoite surface pro-
tein-1 (MSP-1) gene block 2–specific primer pairs,18 the P.
falciparum MSP-2 gene IC1 and FC27 primer pairs,19 and
primer pairs flanking the variable repeats of the glutamate-
rich protein (GLURP) gene.20
Statistical analysis. Differences in proportions were an-
alyzed by the chi-square test. Analysis of factors affecting
the agglutination capacity of plasmas was done by multiple
linear regression. SigmaStat software (Jandel Scientific, San
Rafael, CA) was used for statistical analysis.
RESULTS
Agglutination properties of plasma samples. All 144
plasma samples were tested for their ability to induce agglu-
tinate each of the five parasite isolates (Figure 1). Overall,
35% (19 of 54) of the preseason (September) samples in-
duced agglutination in one isolate and 11% (6 of 54) did so
in two isolates. The remaining 29 September samples did
not agglutinate any isolates. On average, the preseason sam-
ples agglutinated 0.6 6 0.6 isolates per sample (mean 6
SD). The proportions of plasmas able to agglutinate 0, 1, or
2 parasite isolates were not statistically different between
donors who subsequently came down with clinical malaria
and those who did not (P 5 0.09, by chi-square test). How-
ever, the power of the test to detect differences was relatively
low due to the limited sample size.
Of the 28 acute plasmas, 39% (11) were unable to agglu-
tinate any isolate, while 36% (10), 21% (6), and 4% (1)
agglutinated 1, 2, and 3 isolates, respectively. Average ag-
glutination was 0.9 6 0.9 isolate/plasma sample. The pro-
portions of acute plasmas able to agglutinate one or more
parasite isolates were not statistically different from the pre-
season samples from the same individuals (P 5 0.27, by chi-
square test).
At the end of the malaria season, the situation had
changed dramatically because all 62 plasma samples now
agglutinated at least one parasite isolate. Twenty-six percent
(16) of the samples agglutinated one isolate, while 44% (27),
26% (16), 3% (2), and 2% (1) were able to agglutinate 2, 3,
4, and all 5 isolates, respectively, yielding an average of 2.1
6 0.9 isolates/plasma sample. However, as for the preseason
samples, the difference in the proportions of the postseason
plasmas to agglutinate different numbers of isolates was not
statistically different (P 5 0.08, by chi-square test) between
individuals with and without a previous disease episode, al-
though again the power of the test to detect genuine differ-
ences was suboptimal.
In contrast, the proportion of plasmas able to agglutinate
different numbers of isolates after the transmission season
was significantly different from that before the season. This
was true regardless of whether all samples were analyzed
together, or separated into those with (Figure 2) and without
(Figure 3) clinical episodes during the season (P , 0.001 in
all cases, by chi-square test).
Thus, plasma agglutination capacity increased markedly
over the transmission season, although agglutination capac-
ity did not appear to play a significant role in protection
against clinical malaria, at least in the short term. This con-
clusion is supported by analysis of all the agglutination data
by multiple linear regression. This analysis used time of
sampling, whether the donor had a clinical episode, and do-
nor age as independent variables to predict the number of
parasite isolates agglutinated by a given sample. Only the
first of these variables (i.e., sampling before or after the
transmission season) significantly affected this number (P ,
0.001).
A plasma pool from Danish donors who had not been
exposed to malaria did not induce agglutination in any of
the isolates.
Agglutination capacity in relation to clinical history.
We examined whether there were differences in the clinical
histories between the individuals from whom preseason plas-
ma agglutination data were available with respect to the ag-
glutination capacity of their preseason samples. This was
done to test whether individuals who were known to have
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FIGURE 1. Proportions of plasma samples able to agglutinate parasite isolates in relation to time of sampling. Samples were collected before
the malaria season, during acute clinical malaria attacks, and after the malaria season from individuals who did (left) or did not (right)
experience a clinical malaria attack during the malaria season. The proportions of samples able to agglutinate 0, 1, 2, 3, 4, and 5 isolates are
indicated by no, light, medium, dark, very dark, and black shading, respectively.
had a clinical malaria episode in the previous 12 months (31
of 54) were more likely to be able to agglutinate parasitized
red blood cells than those who had not had malaria in the
past year (23 of 54). There were no statistically significant
differences in this respect between those whose preseason
samples were able to agglutinate 0, 1, or 2 parasite isolates,
respectively. Thus, the recent malaria clinical history of the
individuals had no apparent impact on the ability of the pre-
season samples to induce agglutination. This suggests either
that at least some species of agglutinating antibodies are of
very short duration, or that there are marked differences be-
tween the target antigens of agglutinating antibodies present
in any given season and the next.
Parasite isolate characterization by agglutination. The
characteristics of the five parasite isolates used in the agglu-
tination assays are summarized in Table 1. Two isolates (2I4
and X7) were readily agglutinated by a large proportion of
the plasmas, particularly by postseason plasmas, while two
(2A3 and 2I1) were only infrequently agglutinated, and not
by preseason and acute plasmas. No isolates were aggluti-
nated by the three autologous preseason plasmas available,
and only one of five were agglutinated by the autologous
acute plasma sample (Figure 2). In contrast, four of five of
the isolates were agglutinated by postseason autologous plas-
ma (Figure 2). All isolates were agglutinated least by pre-
season plasmas, and most by postseason plasmas, with acute
plasmas being intermediate. This correlation was statistically
significant in all cases (P 5 0.02–0.001, by chi-square test).
Strikingly, the parasite isolates were agglutinated equally
well by plasmas from donors with and without clinical ma-
laria episodes, both preseasonally (P . 0.87, by chi-square
test; only isolates 2I4 and X7 were tested) and postseason-
ally (P 5 0.1–0.8 in all cases, by chi-square test).
The age of the isolate donor correlated inversely with the
number of plasmas able to agglutinate the isolate, although
not reaching conventional statistical significance (P 5 0.10,
r 5 20.81).
Parasite detection and genotyping by PCR. Three of the
isolates (X7, 2I4, and 2I1) amplified single alleles in each
of the MSP-1, MSP-2, and GLURP genotyping assays. Giv-
en that the blood stream forms of P. falciparum are haploid,
this result is consistent with each of these isolates being a
single clone. The remaining two isolates (2A3 and 2L5) am-
plified more than one allele in these genotyping assays, and
were deduced to contain a minimum of two and three clones,
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FIGURE 2. Agglutination of five different parasite isolates by plasma samples obtained before and after the malaria season, and during acute
disease, from 31 individuals experiencing clinical malaria episodes during the season. Degree of agglutination is represented on a five-level
semiquantitative scale.7 Autologous isolate/plasma combinations are emphasized by the heavy frames. X 5 no sample available.
respectively. None of the isolates were identical for all the
markers examined.
Twenty-four percent (13 of 54) of the blood samples col-
lected in September had a P. falciparum parasitemia that was
detectable by nested PCR analysis,12 yet was not detected by
conventional light microscopy of Giemsa-stained smears. Of
these, six of 21 were from individuals who subsequently
came down with clinical malaria in that season, while seven
of 33 were from individuals who did not. Thus, the propor-
tions were similar in these two groups of donors (P 5 0.77,
by chi-square test), indicating that the presence of PCR-de-
tectable P. falciparum infection prior to the transmission sea-
son does not predict subsequent clinical disease. All 26 acute
samples examined tested positive by PCR (as by microsco-
py), while 19% (12 of 62) of the postseason samples were
positive by PCR (but negative by microscopy). Of these lat-
ter samples, six of 29 were from donors who had had a
malaria attack that season, and six of 33 were from donors
who had not had a malaria attack that season (P 5 0.94, by
chi-square test).
DISCUSSION
Agglutinating antibody responses targeted at parasite-de-
rived erythrocyte surface antigens during and following clin-
ical malaria episodes are potentially important protective im-
mune responses that may control parasite infections.21 These
parasite-derived erythrocyte surface antigens are currently
thought to mediate mature asexual stage sequestration and
clonal antigenic variation.22 It is likely that all of these prop-
erties of P. falciparum infections are mediated by the vari-
able erythrocyte surface antigens, now known as PfEMP-1,23
encoded by the var genes.4–6 It has also been shown that the
immunologic capacity to recognize PfEMP-1 serotypes cor-
relates with age in humans living in areas of high malaria
endemicity. Thus, children are generally able to recognize
only a limited number of serotypes, whereas clinically im-
mune adults have antibodies capable of recognizing many
more antigenic types.9, 10
This study was conducted in an area mesoendemic for
malaria, where malaria morbidity is restricted to a three-
month period at the end of the annual rainy season. Patent
parasitemia outside this period is rarely seen. The entomo-
logic inoculation rate in the area has been estimated to be
approximately 0.6 infective bites per person per year (Hamid
AA, unpublished data). However, intensity of transmission
is subject to large fluctuations between years because the
area is prone to droughts when parasite prevalence may de-
crease to very low values (Elhassan IM, unpublished data).
It is possible that under these conditions even older individ-
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FIGURE 3. Agglutination of five different parasite isolates by plasma samples obtained before and after the malaria season from 33
individuals without clinical malaria episodes during the season. See Figure 2 for additional information.
TABLE 1
Agglutination characteristics of Plasmodium falciparum isolates*
Isolate
Donor age
(years)
Preseason
CE
(n 5 21)
NCE
(n 5 33)
Clinical episode
(n 5 28)
Postseason
CE
(n 5 29)
NCE
(n 5 33)
2I4
X7
2L5
2A3
2I1
10
12
17
20
32
0.38 (8)
0.19 (4)
0
0
0
0.36 (12)
0.18 (6)
0.03 (1)
0
0
0.39 (11)
0.25 (7)
0.25 (7)
0
0
0.69 (20)
0.90 (26)
0.45 (13)
0.17 (5)
0.21 (6)
0.55 (18)
0.85 (28)
0.27 (9)
0.03 (1)
0.15 (5)
Overall — 0.11 0.12 0.18 0.48 0.37
* CE 5 clinical episode during the season; NCE 5 no clinical episode during the season. Values are the fraction of all plasmas (N) agglutinating an isolate.
uals do not reach a level of immunity where they possess
agglutinins able to recognize most or all parasite isolates, in
contrast to what is seen in areas of high endemicity.7, 9, 10, 24, 25
Consistent with this reasoning, we found that more than half
of the plasma samples collected at the beginning of the ma-
laria season were unable to agglutinate any of the parasite
isolates used, and only about 10% agglutinated more than
one isolate. Similar low figures were found when examining
plasmas from patients with acute malaria, in line with pre-
vious data.7 In contrast, all plasma samples collected at the
end of the season (at least 30 days after the last clinical
episode seen in the village) agglutinated at least one of the
five parasite isolates collected in the village that season.
More than 80% of these plasma samples agglutinated two
or more parasite isolates. In a study from The Gambia,
Marsh and others10 found levels of agglutinating antibodies
to be the only in vitro parameter correlating with protection.
However, when comparing agglutination in the postseason
samples from donors with and without preceding clinical
episodes in the present study, also conducted in an area of
seasonal, but much lower, malaria transmission, we were un-
able to detect any difference in plasma agglutination be-
tween these groups.
Significantly, our data demonstrate for the first time that
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acquisition of agglutinating antibodies can occur in the ab-
sence of clinical disease. This implies that seroconversion to
recognition of the considered target of agglutinating anti-
bodies, i.e., the antigenically variable PfEMP-1 molecule, is
occurring during chronic asymptomatic infections. That a
marked proportion of infections in this area run a subclinical
course is corroborated by our finding of PCR-detectable in-
fections at the end of the season in approximately 20% of
the donors without clinical episodes, and by our previous
serologic and PCR data from the same area.11, 12
It has been speculated that acquisition of clinical immu-
nity to malaria is associated with accumulation of a sufficient
diversity of strain-specific agglutinating antibodies to enable
recognition of a large proportion of parasite isolates (pan-
agglutination).26 However, we did not find any association
between age and agglutinins in the present study, and per-
haps the rate at which individuals are exposed to different
parasite strains in our study area is simply too low to make
such an association apparent. On average, irrespective of
age, individuals in Daraweesh have an attack of clinical ma-
laria once every 2–3 years.
An alternative explanation is that the variability of para-
site strains transmitted within the small community we have
studied may be lower than those in previous studies, at least
as far as antigens mediating agglutination are concerned. We
do not favor this explanation since the parasite population
in our study area has been demonstrated to be genetically
diverse.27–30
We believe that this study constitutes an important addi-
tion to the surveys previously carried out7, 9, 24, 25 in demon-
strating marked seasonal variation and lack of age structur-
ing in agglutination capacity and seroconversion in the ab-
sence of clinical disease in an area of low and unstable ma-
laria transmission.
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